Mycobacterium avium complex pulmonary disease in immunocompetent patients

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Mycobacterium avium complex is becoming increasingly recognized as one of the most common mycobacterial pathogens in humans. It is rapidly becoming a significant cause of pulmonary disease even in those with an intact immunity. In 1997, the American Thoracic Society published recommendations for the diagnosis and treatment of nontuberculous mycobacteria. On the basis of the authors' clinical experience of the myriad presentations of pulmonary Mycobacterium avium complex disease in an immunocompetent host, a clinical classification is proposed. The current data are summarized, and a practical approach to management of the various pulmonary forms of the disease is provided.

Original languageEnglish (US)
Pages (from-to)646-652
Number of pages7
JournalSouthern medical journal
Issue number6
StatePublished - Jun 2005
Externally publishedYes


  • Bronchiectasis
  • Hypersensitivity pneumonitis
  • Mycobacteria
  • Mycobacteria other than tuberculosis (MOTT)

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Mycobacterium avium complex pulmonary disease in immunocompetent patients'. Together they form a unique fingerprint.

Cite this